Patrick G. O’Connor, M.D., M.P.H., F.A.C.P.

40 ára afmælisráðstefna SÁÁ
Patrick G. O’Connor, MD, MPH, Professor of General Medicine, Chief, General Internal Medicine, Yale School of Medicine

Dr. Patrick O’Connor is a Dan Adams and Amanda Adams Professor of General Medicine and Chief of General Internal Medicine at Yale University School of Medicine and Yale-New Haven Hospital in New Haven, Connecticut. Dr. O’Connor came to Yale as a fellow in the Robert Wood Johnson Clinical Scholars Program during which time he also received a M.P.H. from the Yale School of Public Health. As Chief of General Internal Medicine at Yale he led several new initiatives in patient care, education, and research and has overseen a 3-fold expansion in the size of the faculty and 10-fold increase in research funding.

Dr. O’Connor’s research has focused on the interface between primary care and addiction medicine. Specific topics within his research area have included: 1) the integration of primary care and substance use disorder treatment services, 2) strategies for primary care-based opioid detoxification and opioid maintenance for the treatment of opioid use disorder, 3) strategies for managing unhealthy alcohol use and alcohol use disorder in primary care settings, 4) medical education about addiction, and 5) addiction health policy. He has written over 200 scientific papers on these topics and his work has been published in leading medical journals including The New England Journal of Medicine, and JAMA. Among these publications is the first randomized trial of buprenorphine in primary care. More recently, he served as an author on Facing Addiction in America. The Surgeon General’s Report on Alcohol, Drugs, and Health. His research has been funded through the receipt of numerous grants from the NIH, other federal agencies, and from foundations. He has also collaborated with federal agencies such as The White House Office on Drug Control Policy and with addiction-focused organizations in academia and the private sector.

As Yale’s Chief of General Internal Medicine, Dr. O’Connor has recruited several leading clinical investigators whose work focuses on critical topics in health outcomes and health services research on issues such as cancer, cardiovascular disease, HIV, stroke, health disparities, and patient safety. His faculty includes several physician-investigators and clinician educators whose work focuses on addiction and he has established The Yale Program in Addiction Medicine. He is also the Co-PI on two NIDA-funded career development programs: The Yale Drug use, Addiction, and HIV Research Scholars (DAHRS) program, and The Research in Addiction Medicine Scholars (RAMS) Program.

In the area of addiction medicine, Dr. O’Connor has received numerous national honors for his efforts in research, education, and patient care. He is Immediate Past President of the American Board of Addiction Medicine (ABAM) and the Addiction Medicine Foundation (TAMF), PastPresident of the Association for Medical Research and Education in Substance Abuse (AMERSA) and is a member of the new Addiction Medicine Examination Committee for the American Board of Preventive Medicine. As Chief of the Section of General Internal Medicine at Yale he was recognized with his receipt of the first annual Chief’s Recognition Award from the Society of General Internal Medicine (SGIM) and the Association of Chiefs of General Internal Medicine (ACGIM). He will receive the McGovern Award from AMERSA in November 2017.